Qiagen N.V. (QGEN)
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing
Tarsus Pharmaceuticals Inc (TARS)
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
DexCom Inc (DXCM)
DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors
Ultragenyx Pharmaceutical Inc (RARE)
Ultragenyx to Host Conference Call for Third Quarter 2025 Financial Results and Corporate Update
Arrowhead Pharmaceuticals Inc (ARWR)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Akebia Therapeutics Inc (AKBA)
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
OraSure Technologies Inc (OSUR)
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
Enhabit Inc (EHAB)
Enhabit Announces Participation in UBS Global Healthcare Conference 2025
Chemed Corp (CHE)
Chemed Reports Third-Quarter 2025 Results
Lifestance Health Group Inc (LFST)
LifeStance to Present at the UBS Global Healthcare Conference